The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: A case-control study

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5349-5357

  Chu, Haiyan ^a,b   Ma, Lan ^a,b   Wang, Meilin ^a,b   Shi, Danni ^a,b   Qin, Chao ^b   Yuan, Lin ^c   Yin, Changjun ^b   Zhang, Zhengdong ^a,b  

^a Nanjing Medical University   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bladder cancer; CART; Genetic susceptibility; MDR; Molecular epidemiology; Polymorphism

Indexed keywords

ARGININE; GLUTAMINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PROLINE; SERINE; IL4 PROTEIN, HUMAN; IL4R PROTEIN, HUMAN; INTERLEUKIN 4 RECEPTOR ALPHA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERLEUKIN 13 GENE; INTERLEUKIN 4 GENE; INTERLEUKIN 4 RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; ASIAN; BIOLOGICAL MODEL; BLADDER TUMOR; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY; SMOKING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENES, NEOPLASM; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84863772290     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1334-9     Document Type: Article

References (36)

1. Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A (2010) Bladder Cancer Working Group report. Jpn J Clin Oncol 40(Suppl 1):i57-i64
2. Parkin DM (2004) International variation. Oncogene 23(38): 6329-6340
3. Hainaut P, Pfeifer GP (2001) Patterns of p53 G?T transversions in lung cancers reflect the primary mutagenic signature of DNAdamage by tobacco smoke. Carcinogenesis 22(3):367-374
4. Ames BN, Gold LS, Willett WC (1995) The causes and prevention of cancer. Proc Natl Acad Sci USA 92(12):5258-5265
5. Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117(4):1162-1172
6. Noguchi E, Nukaga-Nishio Y, Jian Z, Yokouchi Y, Kamioka M, Yamakawa-Kobayashi K, Hamaguchi H, Matsui A, Shibasaki M, Arinami T (2001) Haplotypes of the 50 region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 62(11):1251-1257
7. Mitsuyasu H, Izuhara K, Mao XQ, Gao PS, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin JM (1998) Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 19(2):119-120
8. Kruse S, Japha T, Tedner M, Sparholt SH, Forster J, Kuehr J, Deichmann KA (1999) The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 96(3):365-371
9. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337(24):1720-1725
10. Palmer LJ, Daniels SE, Rye PJ, Gibson NA, Tay GK, Cookson WO, Goldblatt J, Burton PR, LeSouef PN (1998) Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children. Am J Respir Crit Care Med 158(6):1825-1830
11. Callard RE, Matthews DJ, Hibbert L (1996) IL-4 and IL-13 receptors: are they one and the same? Immunol Today 17(3): 108-110
12. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1(6): 515-520
13. Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, Wright AL, Halonen M, Klimecki WT, Vercelli D (2006) Th2 cell-selective enhancement of human IL13 transcription by IL13- 1112C[T, a polymorphism associated with allergic inflammation. J Immunol 177(12):8633-8642
14. Graves PE, Kabesch M, Halonen M, Holberg CJ, Baldini M, Fritzsch C, Weiland SK, Erickson RP, von Mutius E, Martinez FD (2000) A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 105(3): 506-513
15. Wang M, Wang M, Yuan L, Wu D, Zhang Z, Yin C, Fu G, Wei Q, Zhang Z (2010) A novel XPF -357A[C polymorphism predicts risk and recurrence of bladder cancer. Oncogene 29(13): 1920-1928
16. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9(7):811-818
17. Zhang H, Bonney G (2000) Use of classification trees for association studies. Genet Epidemiol 19(4):323-332
18. Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene- environment interactions. Bioinformatics 19(3):376-382
19. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69(1):138-147
20. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117(5):1175-1183
21. Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA (2003) Transforming growth factorbeta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte- mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 198(11):1741-1752
22. Nedoszytko B, Niedoszytko M, Lange M, van Doormaal J, Glen J, Zablotna M, Renke J, Vales A, Buljubasic F, Jassem E, Roszkiewicz J, Valent P (2009) Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis. Allergy 64(2):287-294
23. Wang SS, Carreon JD, Hanchard B, Chanock S, Hisada M (2009) Common genetic variants and risk for non-Hodgkin lymphoma and adult T-cell lymphoma/leukemia in Jamaica. Int J Cancer 125(6):1479-1482
24. MalekZadeh K, Nikbakht M, Sadeghi IA, Singh SK, Sobti RC (2010) Overexpression of IL-13 in patients with bladder cancer. Cancer Invest 28(2):201-207
25. Sameni S, Ghayumi MA, Mortazavi G, Faghih Z, Kashef MA, Ghaderi A (2009) Lack of association between interleukin-13 gene polymorphisms (-1055 C/T and ?2044 G/A) in Iranian patients with lung cancer. Mol Biol Rep 36(5):1001-1005
26. Muller-Hermelink N, Braumuller H, Pichler B, Wieder T, Mailhammer R, Schaak K, Ghoreschi K, Yazdi A, Haubner R, Sander CA, Mocikat R, Schwaiger M, Forster I, Huss R, Weber WA, Kneilling M, Rocken M (2008) TNFR1 signaling and IFNgamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13(6):507-518
27. Swain SL, Weinberg AD, English M, Huston G (1990) IL-4 directs the development of Th2-like helper effectors. J Immunol 145(11):3796-3806
28. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC (2007) Allergies, variants in IL- 4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev 31(5):345-351
29. Sugimoto M, Yamaoka Y, Furuta T (2010) Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol 16(10):1188-1200
30. Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, Osorio A, de Oca J, Capella G, Canzian F, Moreno V (2007) Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur J Cancer 43(4):762-768
31. Chen M, Kamat AM, Huang M, Grossman HB, Dinney CP, Lerner SP, Wu X, Gu J (2007) High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 28(10):2160-2165
32. Cozen W, Diaz-Sanchez D, James Gauderman W, Zadnick J, Cockburn MG, Gill PS, Masood R, Hamilton AS, Jyrala M, Mack TM (2004) Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol 24(6):617-622
33. Simhan HN, Caritis SN, Hillier SL, Krohn MA (2005) Cervical anti-inflammatory cytokine concentrations among first-trimester pregnant smokers. Am J Obstet Gynecol 193(6):1999-2003
34. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, Blaser K, Wuthrich B, Simon HU (2002) Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 169(2):1021-1027
35. Margel D, Pevsner-Fischer M, Baniel J, Yossepowitch O, Cohen IR (2011) Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. Eur Urol 59(1): 113-119
36. Zhai R, Chen F, Liu G, Su L, Kulke MH, Asomaning K, Lin X, Heist RS, Nishioka NS, Sheu CC, Wain JC, Christiani DC (2010) Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma. J Clin Oncol 28(14):2445-2451